1.5451.59% ( -0.025 )
Delay Closed: Nov 16, 16:08:11Valuation
Current ValuationThe current P/E ratio is 7.70, below the reasonable range, cheaper than 84.97% of the time in the past 5 years, and the industry ranks 9/53, the industry Median 6.94.
7.7xP/E
HK$1.55Stock price
HK$0.20Earnings per share
7.7xP/E
Stock priceHK$1.55Earnings per shareHK$0.20
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 18.20x
- Typical range
- 9.36x–26.34x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.94x
010203040
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.94x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
03320HKCHINARES PHARMA | 5.90x | 7.23% | HK$28.21B |
01681HKCONSUN PHARMA | 9.90x | 20.92% | HK$13.39B |
02877HKSHINEWAY PHARM | 6.94x | 13.28% | HK$6.43B |
02186HKLUYE PHARMA | 7.70x | 47.27% | HK$6.17B |
02633HKJACOBSON PHARMA | 6.00x | 1.99% | HK$1.81B |
08049HKJILIN CHANGLONG | 6.47x | -- | HK$1.63B |
02348HKDAWNRAYS PHARMA | 5.02x | -- | HK$1.34B |
02161HKJBM HEALTHCARE | 6.15x | 6.78% | HK$1.24B |
00239HKPAK FAH YEOW | 7.45x | -- | HK$737.03M |
00950HKLEE'S PHARM | 4.97x | -- | HK$594.72M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
